Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Park Prosecutions Are Expected To Continue: Here Are Some Tips

Executive Summary

The US Department of Justice is expected to continue ramping up its scrutiny of individuals under what’s called the Park Doctrine, attorneys say. The best defense may be taking awareness to the board of directors, they claim.

You may also be interested in...



US Health-Care Enforcement Focus Continues To Expand, Officials Say

Reimbursement efforts, individual liability and innovative corporate integrity agreements were among areas of focus at a recent Food and Drug Institute enforcement forum.

Acclarent Execs Move To Appeal Off-Label Conviction

Attorneys for former Acclarent executives William Facteau and Patrick Fabian have filed a request that their convictions on off-label marketing charges either be set aside or that they be granted a new trial, citing other recent off-label trials and misconduct by the government.

Stronger Focus On Targeting Corporate Executives In DoJ Manual Update

The updated US Attorney’s Manual instructs government lawyers to focus on individuals from the launch of civil or criminal investigations into a company, and not to consider individual’s ability to pay a judgment in deciding whether to pursue charges.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103837

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel